首页> 外国专利> RECOMBINANT ANTIGEN, RSM14, COMING FROM SCHISTOSOMA MANSONI, ITS OBTAINING AND USE.

RECOMBINANT ANTIGEN, RSM14, COMING FROM SCHISTOSOMA MANSONI, ITS OBTAINING AND USE.

机译:来自曼氏血吸虫的重组抗原RSM14,其获得和使用。

摘要

RECOMBINANT ANTIGEN, RSM14, COMING FROM CVASCHISTOSOMA MANSONI, ITS OBTAINING AND USE. THE RSM14 RECOMBINANT ANTIGEN IS A FUSION PROTEIN THAT INCLUDES A POLYPEPTIDE CHAIN DERIVED FROM A BACTERIOPHAGUS LINKED TO THE NATIVE POLYPEPTIDE CHAIN OF THE MANSONI CVASCHISTOSOMA PROTEIN BY A PEPTIDIC LINK. THE ANTIGEN MAY BE OBTAINED BY EXPRESSION OF A TRANSFORMED MICROORGANISM AND MAY BE USED AS A VACCINE AGAINST DISEASES CAUSED BY THE HELMINTIC INFECTIONS OF HUMANS AND ANIMALS, IN PARTICULAR, THEY ARE CAUS BY LAASASISO, SPECIES OF FASCIOLIASIS.
机译:重组抗原RSM14,来自曼氏猪痘病毒(CVASCHISTOSOMA MANSONI),其获得和使用。 RSM14重组抗原是一种融合蛋白,它包含来源于细菌噬菌体的多肽链,该细菌链是通过肽链与曼森尼CVASCHISTOSOMA蛋白的天然多肽链相连的。可以通过表达转化的微生物来获得抗原,并且可以将其用作针对人类和动物的蠕虫感染所致疾病的疫苗,尤其是它们是由LAASASISO和真菌病引起的。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号